Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2006 Sep;7(9):724-31.
doi: 10.1038/nrn1986.

Neural tube defects and folate: case far from closed

Henk J Blom  1 , Gary M Shaw, Martin den Heijer, Richard H Finnell
Affiliations
Review

Neural tube defects and folate: case far from closed

Henk J Blom et al. Nat Rev Neurosci. 2006 Sep.

Abstract

Neural tube closure takes place during early embryogenesis and requires interactions between genetic and environmental factors. Failure of neural tube closure is a common congenital malformation that results in morbidity and mortality. A major clinical achievement has been the use of periconceptional folic acid supplements, which prevents approximately 50-75% of cases of neural tube defects. However, the mechanism underlying the beneficial effects of folic acid is far from clear. Biochemical, genetic and epidemiological observations have led to the development of the methylation hypothesis, which suggests that folic acid prevents neural tube defects by stimulating cellular methylation reactions. Exploring the methylation hypothesis could direct us towards additional strategies to prevent neural tube defects.

PubMed Disclaimer

Conflict of interest statement

Competing interests statement

The authors declare no competing financial interests.

Figures

Figure 1
Figure 1. Neural tube closure in the developing mouse
A | Four phases of primary neurulation in neural tube closure. Panels a–c are dorsal views, whereas panel d is a lateral view. a–c | Bidirectional fusion beginning from the original initiation site in the mid-cervical region (a), followed by continued bidirectional fusion (b and c) rostrally towards the anterior neuropore (blue shading) and caudally towards the posterior neuropore (green shading), which progresses as a result of convergent extension and apical constriction. Panel d shows a closed neural tube, with complete fusion over the rhomobencephalon, which has yet to be covered externally. Failure of the posterior neural tube to close can result in spina bifida. Defects in the closure of the anterior neural tube could result in anencephaly. B | Stages of neural tube closure in a transverse section. The neural plate elevates to form neural folds, which progressively appose each other, ultimately fusing to create a closed neural tube. This occurs just before the end of the first month of pregnancy. Panel B modified, with permission, from REF. © (2001) Society for Experimental Biology and Medicine.
Figure 2
Figure 2. Structures of folates
The bioactive form of folate is 5,6,7,8-tetrahydrofolate. Although folic acid is not present in nature, it is more stable than other forms of folate and so is the form typically used in tablets and fortified food. Folic acid is reduced to 5,6,7,8-tetrahydrofolate by dihydrofolate reductase via 7,8-dihydrofolate. The function of folate is to provide one-carbon moieties for biosynthetic purposes. The most reduced form of folate is 5-methyltetrahydrofolate (5-MeTHF) and the most oxidized forms are 5-and 10-formyltetrahydrofolate. Polyglutamation prevents transport of folate out of the cell. Modified, with permission, from REF. © (2001) Society for Experimental Biology and Medicine.
Figure 3
Figure 3. Simplified folate metabolism
In the circulation, folate is mainly present as 5-methyltetrahydrofolate (5-MeTHF), which is taken up by cells via specific carriers or receptors. In the cell, folate donates one-carbon units for use in methylation reactions and in purine and thymidine synthesis. Alternatively, folate can also accept one-carbon units from several amino acids, including serine. Methylenetetrahydrofolate reductase (MTHFR) competes with thymidylate synthase (TS) and methylenetetrahydrofolate dehydrogenase (MTHFD) for the one-carbon units of 5-MeTHF. MTHFR activity is regulated by S-adenosylmethionine (AdoMet), which inhibits enzyme activity. Vitamin B12 is a cofactor of methionine synthase (MTR) and is involved in the transfer of the methyl group from 5-MeTHF to homocysteine. AdoHcy, S-adenosylhomocysteine; AIRCARFT, aminoimidazolecarboxamide ribonucleotide transformylase; DHF, dihydrofolate; DHFR, DHF reductase; dTMP, deoxythymidine monophosphate; dUMP, deoxyuridine monophosphate; FR, folate receptor; GARFT, glycinamide ribonucleotide transformylase; MTRR, MTR reductase; RFC, reduced folate carrier; SHMT, serine hydroxymethyltransferase; THF, tetrahydrofolate. Modified, with permission, from REF. © (2003) Oxford University Press.
Figure 4
Figure 4. The three MTHFR genotypes affect methylation and DNA synthesis to different extents
Variations in methylenetetrahydrofolate reductase (MTHFR) activity influence the flux through the different folate pathways. The MTHFR 677 CC genotype produces the variant with the highest enzymatic activity. This results in lower concentrations of 5,10-methylenetetrahydrofolate (5,10-methylene THF) and 10-formyl THF available for DNA synthesis and higher concentrations of 5-methyl THF available for adequate levels of methylation. The CT genotype produces an intermediate effect. Finally, the TT genotype produces the variant with the lowest MTHFR activity and leads to higher concentrations of 5,10-methylene THF and 10-formyl THF for DNA synthesis, and lower concentrations of 5-methyl THF. Consequently, there is a reduction in the extent of methylation, which could result in an increased risk of neural tube defects.
Figure 5
Figure 5. Folate metabolism is influenced by environmental and genetic factors
Intake of B vitamins other than folate, such as vitamin B12, B6 and B2, also affects folate metabolism. This process can also be disrupted by genetic variants, with an elegant example being the MTHFR 677C>T polymorphism. Disruption of the methylation of lipids, DNA and proteins during early embryogenesis could lead to neural tube defects (NTDs). It is proposed that folate prevents NTDs by increasing methylation of various molecules that are essential to cellular processes.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Elwood JM, Little J, Elwood JH. Epidemiology and Control of Neural Tube Defects. Oxford Univ. Press; 1992.
    1. Waitzman NJ, Romano PS, Scheffler RM. Estimates of the economic costs of birth defects. Inquiry. 1994;31:188–205. - PubMed
    1. Hall JG, et al. Clinical, genetic, and epidemiological factors in neural tube defects. Am J Hum Genet. 1988;43:827–837. - PMC - PubMed
    1. Copp AJ, Greene NDE, Murdoch JN. The genetic basis of mammalian neurulation. Nature Rev Genet. 2003;4:784–793. Excellent review of mammalian neurulation. - PubMed
    1. Detrait ER, et al. Human neural tube defects: developmental biology, epidemiology, and genetics. Neurotoxicol Teratol. 2005;27:515–524. - PMC - PubMed

Publication types

MeSH terms